Tag Archives: New drugs may help prevent hospitalization from COVID-19

An experimental drug showed promise in reducing hospitalizations among patients at high risk of complications from COVID-19, experts from Baylor University Medical Center and the drugmaker Eli Lilly and Company reported Thursday. The study followed 577 patients with mild to moderate COVID-19, some of whom were treated with antibody drugs from Eli Lilly. ‘Pearls for the girls!’ Dallas middle school …

Read More »